baber/WOPTO huggingface dataset:
Patent DE-69609109-T2 (DE)
Inventor: LE THIESSE JEAN-CLAUDE
IPC: C07C43/23
Filed: 1996-04-05
Granted: 2001-02-15
Abstract: Prepn. of crystallised pearls of a prod. showing surfusion comprises: (1) melting the prod. if necessary; (2) fragmenting the melted mass into droplets; (3) cooling the droplets to a temp. below the glass transition temp. of the prod. so the droplets harden by vitrification; (4) keeping the vitrified pearls at a temp. below the Tg and contacting them with crystallisation seeds; (5) crystallising the pearls by raising the temp. to above Tg; and (6) recovering the crystallised pearls. Also claimed are the crystallised pearls produced as above; crystallised pearls of a prod. showing surfusion which has a glass transition and not contg. crystallisation additives; crystallised pearls comprising a least one glyceryl gaiacolate, and an appts. comprising a 1st chamber for forming the pearls, a 2nd chamber for recovering the vitrified pearls and a 3rd chamber for crystallising the vitrified pearls.
Patent DE-69615656-T2 (DE)
Inventor: SCHRIER CARLA CHRISTINA
IPC: A61K9/12
Filed: 1996-01-04
Granted: 2002-08-01
Abstract: The present invention for the first time discloses a health problem in broilers at about 3-5 weeks, resulting in significant production losses, and demonstrates that these production losses can be prevented by a live attenuated CAA vaccine for mucosal administration.
Patent DE-69618041-T2 (DE)
Inventor: REGAZZI GIANNI
IPC: F02P5/155
Filed: 1996-02-08
Granted: 2002-06-13
Abstract: An inductive-ignition system for internal-combustion engines with electronically controlled spark advance. A voltage generator (10, 12) comprises the primary winding (L1) of an ignition coil (L1, L2) each side of which is connected to the ground by an electronic current-control switch (MOS1, MOS2) the conductive state of which is inhibited by electric signals supplied to the gate (G) of the respective control switch (MOS1, MOS2) by a magnetic pick-up (P1, P2); the two pick-ups (P1, P2) have different number of turns and are angularly spaced apart from one another in the magnetic circuit of the voltage generator (10, 12), to trigger the control switches (MOS1, MOS2) to generate sparks at different running speeds of the engine. An inhibition circuit (23) is provided for maintaining the inhibited state of the two control switches (MOS1, MOS2) allowing the spark to be maintained for the entire time during which the ignition coil (L1, L2) generates a voltage. The system comprises moreover a revolution limiting circuit (T1, T2) for limiting the maximum revolution number of the engine and means (DZ3, RG'K) for eliminating the negative influences of the magnetic system of the voltage generator (10, 12) on the ignition circuit. <IMAGE>
Patent DE-69619342-T2 (DE)
Inventor: FROST JONATHAN CHARLES
IPC: F01N3/20
Filed: 1996-06-05
Granted: 2002-10-02
Abstract: The hydrocarbon light-off time in engine exhaust is reduced by employing a hydrogen oxidation catalyst, a CO oxidation catalyst of light-off temperature for CO and/or hydrogen below ambient temperature, and sufficient oxygen and sufficient CO and/or hydrogen in the exhaust that the exothermic reaction of the oxygen with the CO and/or hydrogen over the CO oxidation catalyst generates enough heat to raise the temperature of the CO oxidation catalyst to at least the light-off temperature of the hydrocarbon oxidation catalyst.
Patent DE-69629834-T2 (DE)
Inventor: MCNEILL ANTHONY
IPC: A01G25/02
Filed: 1996-12-24
Granted: 2004-07-01
Abstract: A flexible plastic water tube which can be stored on a roll has a flexible but substantially inextensible line member attached to it and can include a number of pre-attached drippers. The tube can be stretched between spaced apart supports with the line member preventing undesirable sagging. The tube can therefor be made from inexpensive thin walled plastic.
Patent DE-69633583-T2 (DE)
Inventor: BURET ANDRE G
IPC: A61P31/04
Filed: 1996-05-09
Granted: 2006-02-23
Abstract: A new use of epidermal growth factor (EGF) for preparing an agent for increasing weight gain in an animal is described. The agent is preferably formulated as a food additive or drinking water additive and administered in the feed of the animal. Another use of EGF is for preparing a medicament for treating malnourished people and persons suffering from anorexia nervosa. As such EGF can be used to increase animal production, for example in the agriculture or aquaculture industry.
Patent DE-69704703-T2 (DE)
Inventor: MAXWELL HUGH
IPC: C23C14/16
Filed: 1997-01-31
Granted: 2002-01-31
Abstract: Disclosed is an improved bond coat of a thermal barrier coating system useful for enhancing adhesion of a ceramic topcoat to a superalloy substrate. The bond coat includes about 13 to 30 weight percent aluminum, between trace and about 3 weight percent of a reactive element selected from the group consisting of yttrium, zirconium, lanthanum, and scandium, and mixtures thereof, and balance selected from the group consisting of nickel, cobalt, iron and mixtures thereof, wherein said bond coat is further characterized by absence of added chromium. A preferred method includes plasma spraying a prealloyed powder of the bond coat composition on the substrate followed by alumina formation and ceramic topcoat deposition. Uses include thermal barrier coating systems on gas turbine engine hot section components such as turbine blade and vane airfoils, combustors, and exhaust nozzles.
Patent DE-69704778-T2 (DE)
Inventor: SCHICKANEDER HELMUT
IPC: C07H17/08
Filed: 1997-08-07
Granted: 2001-09-20
Abstract: N-acetylcysteine, carboxymethylcysteine and thiazolidincarboxylic acid salts of erythromycin-2-propionate are produced by charging erythromycin-2-propionate and the sulphur-containing acid into a reactor. The reactants are homogenised and milled under nitrogen for 1 - 2 hours at 10 - 20  DEG C. To this mixture purified water is added under nitrogen and the resultant aqueous mixture is further homogenised and milled for 1 to 2 hours at 10 - 30  DEG C under nitrogen to produce a suspension of the desired salt. The suspension is dried under vacuum to produce a high yield of the desired salt at high levels of purity. Carboxymethylcysteine, N-acetylcysteine and thiazolidin-carboxylic acid salt of erythromycin, clarithromycin, roxithromycin and azithromycin may be produced in a similar manner.
Patent DE-69732980-T2 (DE)
Inventor: HELEWA MAYER
IPC: A61G9/00
Filed: 1997-07-21
Granted: 2006-05-04
Abstract: A flexible, impervious and incinerable single-use covering (Fig. 1) for a conventional bedpan is disclosed. The covering may be adapted to the receptacles into which it is inserted, and is made of two polygonal sheets (1) joined together by welds (4, 6, 9, 11) except along the open top edge (2) provided with sliding closures (13) for adjusting and sealing the covering. Said covering contains a gelling agent (8) which prevents liquid leaks and thus makes the covering safe to handle while reducing the risk of contamination and pollution.
Patent DE-69802345-T2 (DE)
Inventor: KIRCH MICHEL
IPC: A01B33/14
Filed: 1998-07-03
Granted: 2002-07-25
Abstract: The working tool (30) is designed to rotate around its own vertical axis (x-x') and consists of an active working part (30b), a linking section (30a), which is roughly orthogonal to the active part and is designed to secure the tool to the machine. The linking section is provided with an opening (34) to allow the tool to be held in place and a tongue (33) and a finger (35), which fit into housings (6), located on the machine. The cross section, of the linking part of the tool, taken at right angles to the longitudinal axis of the tongue and passing through the tongue, presents a first part, which is roughly rectangular. It also presents a second part, or parts, which have increased thickness relative to the first part and have a shape, which is at least partially rounded, or circular, with the first part forming the tongue and second part the finger.
Patent DE-69809957-T2 (DE)
Inventor: MCMEEKING JOHN
IPC: C08F110/02
Filed: 1998-09-03
Granted: 2003-09-04
Abstract: A catalyst system comprises an organometallic complex of a group 4 metal having a ketimide ligand. The organometallic complex preferably also contains a cyclic ligand which forms a delocalized pi-bond with the metal (such as a cyclopentadienyltype ligand). Preferred organometallic complexes may be activated with a so-called "substantially non coordinating anion" to form a low cost cocatalyst system which is excellent for the preparation of olefin copolymers having both high molecular weight and very low density.
Patent DE-69813573-T2 (DE)
Inventor: ALVAREZ-VALLINA LUIS
IPC: A61K35/26
Filed: 1998-09-07
Granted: 2004-02-26
Abstract: Disclosed is a method of regulating the expression in a human or animal subject of a nucleic acid sequence encoding a polypeptide which is immunogenic in the subject; the method comprising introducing into the subject a cell comprising the nucleic acid sequence encoding the immunogenic polypeptide, said sequence being operably linked to a drug-regulatable promoter; and altering the concentration of regulatory drug to which the cell is exposed.
Patent DE-69816460-T2 (DE)
Inventor: ALLAN GORDON
IPC: C12N15/34
Filed: 1998-10-01
Granted: 2004-05-27
Abstract: A purified preparation of type II porcine circovirus (PCV). Independent claims are also included for the following: (a) preparation of PCV (i) isolated from a physiological or tissue sample, particularly from a lesion, from a pig with symptoms of PMWS (porcine multisystemic wasting syndrome); or (ii) produced by, and isolated from, in vitro cell cultures infected with the virus of (i); (b) extract or culture supernatant, or antigen preparation, optionally purified, collected from in vitro cultures of cells infected with PCV; (c) vaccine containing the products of (b); (d) DNA fragments (A) of 1767 bp (1), 1767 bp (2), 1767 bp (3), 1768 bp (4) or 1768 bp (6), or containing an open reading frame (ORF) of PCV; (e) polypeptides (I) encoded by (A) or these ORF; (f) in vitro expression vector containing (A), or these ORFs; (g) polypeptides (Ia), optionally purified, expressed from the vector of (f); (h) subunit vaccine containing at least one (I) or (Ia), diluent or vehicle and optionally an adjuvant; (i) in vivo expression vector, integrated into a genome, containing (A) or the ORFs; (j) live or plasmid vaccine containing the vector of (j), and a diluent or vehicle; (k) probe or primer containing all or part of (A) or the ORFs; (l) mono- or poly-clonal antibodies raised against PCV, (I), (Ia) or their fragments; and (m) detection of PCV by identifying in a body fluid or tissue sample an antigen or antibody specific for the antigen. ACTIVITY : Antiviral. MECHANISM OF ACTION : Induction of an immune response against porcine circovirus; vaccine.
Patent DE-69819690-T2 (DE)
Inventor: JANEK GABOR
IPC: G10L15/06
Filed: 1998-12-14
Granted: 2004-08-12
Abstract: In a product including a speech recognition device for controlling at least one processing unit while using a command lexicon containing commands which depends as regards its contents on an activated operating state of a processing unit and which speech recognition device includes a command lexicon memory in which commands of the command lexicon can be stored in the form of command information and identification information assigned to the latter, and which speech recognition device includes speech recognition means for detecting command information-contained in speech information representing a spoken command-and delivers command information to the at least one processing unit, generating means are provided which are arranged for generating-after an operating state of a processing unit has been activated-which may be effected with the aid of command information detected in a spoken command-a command lexicon assigned to only this one activated operating state and for storing this command lexicon in the command lexicon memory.
Patent DE-69827060-T2 (DE)
Inventor: WILL STEPHEN GORDON
IPC: C12Q1/686
Filed: 1998-03-12
Granted: 2005-03-24
Abstract: The present invention provides modified oligonucleotides for use in the amplification of a nucleic acid sequence. Amplifications carried out using the modified oligonucleotides result in less non-specific amplification product, in particular, primer dimer, and a concomitant greater yield of the intended amplification product compared to amplifications carried out using unmodified oligonucleotides as primers.
Patent DE-69830326-T2 (DE)
Inventor: MARCIANI J
IPC: A61K39/00
Filed: 1998-10-02
Granted: 2006-02-02
Abstract: The present invention relates to polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells, conjugated to one or more compounds having stable carbonyl groups covalently attached, either directly or via a bifunctional linker. The conjugates are useful as immuno-stimulants and adjuvants.
Patent DE-69835517-T2 (DE)
Inventor: NAGOYA MITSUGU
IPC: G01R31/28
Filed: 1998-06-02
Granted: 2007-08-09
Abstract: There are provided a boundary scan element including a plurality of input-terminal-side boundary cells connected in series and assigned individually to respective input terminals, a plurality of output-terminal-side boundary cells connected in series and assigned individually to respective output terminals, a TAP circuit for controlling input and output of data to or from the input-terminal-side and output-terminal-side boundary cells, a TDI terminal for inputting serial data to be provided to the boundary cells, a TDO terminal for outputting data from the boundary cells as serial data, a TCK terminal to which a clock signal is input, and a TMS terminal to which a mode signal is input to switch an operation mode of the TAP circuit, characterized in that the input-terminal-side boundary cells and the output-terminal-side boundary cells are connected in parallel between the TDI terminal and the TDO terminal; and a communication system using the same. <IMAGE>
Patent DE-69835844-T2 (DE)
Inventor: LINDSTROM KYLE J
IPC: A61K31/4745
Filed: 1998-12-11
Granted: 2007-04-19
Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
Patent DE-69836783-T2 (DE)
Inventor: CHAPPELL PHILLIP BRANCH
IPC: C07D209/08
Filed: 1998-09-04
Granted: 2007-10-31
Abstract: The use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating Tourette's syndrome, obsessive compulsive disorder, chronic motor or vocal tic disorder in a mammal, including a human <CHEM> wherein n, X, Y and Ar are as defined herein.e
Patent DE-69837399-T2 (DE)
Inventor: ONO KOICHIRO
IPC: G01N33/53
Filed: 1998-10-22
Granted: 2007-12-20
Abstract: A method of screening substances which inhibit the bonding of TAK1 polypeptide to TAB1 polypeptide, characterized by contacting TAK1 polypeptide and a sample with TAB1 polypeptide and detecting or determining the TAK1 polypeptide bonded to the TAB1 polypeptide.
Patent DE-69837738-T2 (DE)
Inventor: TSUTSUI KYOYA
IPC: H04B1/66
Filed: 1998-03-25
Granted: 2008-01-31
Abstract: An encoding method and apparatus and a decoding method and apparatus in which the encoded information is decreased in volume and in which the encoding and decoding operations are performed with a smaller processing volume and a smaller buffer memory capacity. The apparatus includes a low range signal splitting circuit (261g, 261h) for separating low-range side signal components (260c,260d) from L and R channel signals (260a,260b) converted by a transform circuit into spectral signal components, and a channel synthesis circuit (261e) for synthesizing (L+R) channel signal components from the L and R channel spectral signal components (260c,260d). The apparatus also includes a high range signal separating circuit (261f) for separating the high range side signal components (260h) from the (L+R) channel signal components (260a,260b), a signal component encoding circuit (261j,261k) for compression-encoding low-range side signal components and a signal component encoding circuit (261i) for compression-encoding the normalization coefficient information obtained on normalization of the (L+R) channel high-range signal components. <IMAGE>
Patent DE-69902812-T2 (DE)
Inventor: RUDEEN W
IPC: G02B27/28
Filed: 1999-11-04
Granted: 2003-04-24
Abstract: An optical element has a coating thereon to reflect energy, such as light, of a first polarization into a first focus zone and to allow energy, such as light, of a second polarization orthogonal to the first polarization, to reach a second optical element. The second optical element, which may be reflective, diffractive, holographic, aspherical or have other optical characteristics, acts upon the energy to focus it into a second focus zone. A polarization changing element can be placed between the energy source and the optical element or the polarization can be changed by rotating the energy source. The ability to position energy into different focus zones allows for high speed processing and for the generation of useful beam patterns, such as aiming beams.
Patent DE-69903557-T2 (DE)
Inventor: DAUVOIS JEAN-LUC
IPC: H04L29/06
Filed: 1999-07-14
Granted: 2003-06-26
Abstract: The present invention relates to a method of providing secure communication of information between at least a first and second digital audiovisual device ( 30, 52 ) and characterized in that the first device ( 30 ) communicates to the second device ( 52 ) a certificate Ct(KpubT) comprising a transport public key KpubT encrypted by a management private key KpriMan, the second device ( 52 ) decrypting the certificate using an equivalent management public key KpubMan and thereafter using the transport public key KpubT to encrypt information sent to the first device, the first device using an equivalent private key KpriT to decrypt the information. The present invention is particularly applicable to a method of providing secure communication between a first and second decoder.
Patent DE-69907914-T2 (DE)
Inventor: LANIER THIERRY
IPC: A41D31/00
Filed: 1999-07-23
Granted: 2004-01-15
Abstract: A textile complex is provided including at least a fabric, a textile lap, made of inflammable material, designed to form the external surface of the complex, and a comfort and hygiene lining designed to form the complex internal surface. On the fabric internal surface and/or the lining external surface folds are provided having substantially the same orientation with respect to each other, fixed on the fabric and/or the lining, and defining between the fabric and the lining air-filled passages.
Patent DE-69910769-T2 (DE)
Inventor: PARETI VITTORIO
IPC: B23D61/02
Filed: 1999-05-20
Granted: 2004-06-17
Abstract: The invention is in the field of cutting disks employed in the construction industry for cutting concrete and construction materials in general and in industrial applications for cutting wood, glass and metals. More specifically the invention relates to a sheet (1) able to be attached to the cutting disk. The sheet comprises one or more layers (3) of synthetic fabric such as carbon fibre, glass fibre, or combinations of carbon fibre with glass fibre. The sheet comprises a layer of adhesive (4) able to adhere to the surface of the cutting disk.
Patent DE-69926141-T2 (DE)
Inventor: KHAN LOKMAN
IPC: C09J161/06
Filed: 1999-11-25
Granted: 2006-05-11
Abstract: Disclosed is a process for modifying cashew nut shell liquid (CNSL) which involves the steps of subjecting the CNSL to ozonolysis to form ozonolysis reaction products, followed by reduction of the ozonolysis reaction products to give a mixture of phenolic components and aldehydes. In a preferred embodiment, the process involves reacting CNSL with ozone to form a mixture containing ozonolysis reaction products, and then treating the mixture under reducing conditions to form a further mixture containing phenolic components with an eight carbon chain having a terminal -CHO group and alkyl components of varying lengths with either one or two terminal -CHO groups. The resulting CNSL aldehydes may be used to form adhesives for use in the manufacture of composites such as wood particle board.
Patent DE-69927275-T2 (DE)
Inventor: HOWE WESLEY
IPC: H04W48/18
Filed: 1999-07-23
Granted: 2006-01-12
Abstract: In a multiple mode communication system (29), a radio communication device (22) selectively communicates, using a common pool of channels (42), through a cordless base station (30) and a cellular network having a plurality of cellular base stations (24). The radio communication device (22) determines and stores local station identifiers (88) for the cellular base stations (24) which are broadcasting message streams (48) over control channels (46) in a cordless radio coverage area (26) of the radio communication device (22). The radio communication device (22) transmits a message to the cordless base station (30) when a detected cellular base station identifier (51) matches one of the determined local station identifiers (88). The radio communication device (22) is prevented from transmitting a message when the detected cellular base station identifier (51) matches none of the local station identifiers (88).
Patent DE-69932281-T2 (DE)
Inventor: HIRATA MICHIMASA
IPC: A61P31/04
Filed: 1999-03-24
Granted: 2007-07-12
Abstract: A peptide comprising at least the following amino acid sequence:   Lys Xa1 Phe Lys Arg Ile Val Xa2 Arg Ile Xaa Xa2 Phe Leu Arg Xa2 Leu Val (SEQ ID NO: 1) wherein, Xa1 represents a hydrophobic amino acid residue, each of Xa2 independently represents a hydrophilic amino acid residue, and Xaa represents an arbitrary amino acid residue; an antimicrobial agent, a medicine including a bacterial infection-treating agent and an endotoxin shock suppressant which each comprise the peptide as an active ingredient; and an endotoxin-removing agent comprising the peptide immobilized to an insoluble carrier.
Patent TR-200000991-T2 (TR)
Inventor: DOOREN THEODORUS JOHANNES GODF
IPC: C12P35/04
Filed: 1998-10-01
Abstract: Process for the preparation of a beta-lactam antibiotic in which a beta-lactam nucleus is subjected to an enzymatic acylation reaction with the aid of an acylation agent at a molar ratio of acylation agent/beta-lactam nucleus of less than 2.5, with the acylation agent and/or the beta-lactam nucleus being supersaturated in the reaction mixture during at least part of the acylation reaction. In the process, a concentrated slurry or solution, for instance, of the beta-lactam nucleus and/or the acylation agent with a different pH or a higher temperature than the pH or temperature at which the acylation reaction is carried out is added to the reaction mixture during the acylation reaction. Both the beta-lactam nucleus and the acylation agent may be supersaturated in the reaction mixture.
Patent TR-200001912-T2 (TR)
Title: Elektrik süpürgesi başlığı.
Inventor: MILLET CHRISTINE
IPC: A47L9/06
Filed: 1999-01-08
Abstract: Bulus bir elektrik süpürgesi basligina iliskin olup, içinde kendi ekseni etrafinda dönebilen bir baglanti bilezigi araciligiyla yukariya ve geriye dogru bir emici tüpe baglanabilen bir hazne, haznenin altinda, dibi girintili bir emme kanali arz eden bir taban, emme kanalinin içine yerlestirilmis bir emme agzi, haznenin altina yerlestirilmis bir kaziyici mekanizmayla arka tekerlekler bulunur. Baglanti bileziginin dönme aksi, tekerlekleri dönme aksinin arkasindadir ya da hem baglanti bilezigi, hem de tekerlekler ayni aks üzerindedir.